Neocor Therapeutics Revenue

Biotechnology Research • La Ciotat, Provence-Alpes-Côte d'Azur, France • 1-10 Employees

Neocor Therapeutics revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	No funding

Key Contact at Neocor Therapeutics

Matthieu Metz

Chief Executive Officer

Company overview

Headquarters	La Ciotat, Provence-Alpes-Côte d'Azur, France
Website	neocor.fr
NAICS	541714
Keywords	Biotechnology, Cardiology, Gene Therapy, Rare Disease
Founded	2023
Employees	1-10

Neocor Therapeutics Email Formats

Neocor Therapeutics uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@neocor.fr), used 60% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@neocor.fr	60%
{last name}{last name}	doedoe@neocor.fr	40%

About Neocor Therapeutics

We are currently developing a novel gene therapy approach targeting ischemic and rare genetic cardiac diseases, and moving from lab preclinical trials to regulatory trials. The Company was founded in October and has received strong traction since inception. We will be looking to strengthen our human and financial ressources in the coming month in order to start the regulatory pre clinical trials.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Neocor Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Neocor Therapeutics has never raised funding before.

Neocor Therapeutics Tech Stack

Discover the technologies and tools that power Neocor Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Isotope

JavaScript libraries

Microsoft 365

Frequently asked questions

Neocor Therapeutics is located in La Ciotat, Provence-Alpes-Côte d'Azur, FR.

Neocor Therapeutics generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.

Neocor Therapeutics has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Neocor Therapeutics was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

Neocor Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Neocor Therapeutics

Matthieu Metz

Chief Executive Officer

4.8

40,000 users